Picture of GO-DX (Aust) logo

GD8 GO-DX (Aust) Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-1.84%
3m+5.37%
6m+2.87%
1yrn/a
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value75.79
Price to Tang. Book75.79
Price to Free Cashflown/a
Price to Sales22,524.12
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-40.44%
Return on Equity-72.63%
Operating Margin-12015.64%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202530th Jun 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of GO-DX (Aust) EPS forecast chart

Profile Summary

GO-Dx Corporation (Aust) Ltd is an Australia-based healthcare technology company specializing in advanced diagnostic and precision medicine solutions. The Company has developed intellectual property comprising an RNA mining/mapping platform designed as a tool to support personalized diagnostics and therapeutics. The RNA Mining/Mapping Platform is a diagnostic tool created for the specific purposes of generating personalized ribonucleic acid (RNA) information for individuals in the form of a graph. Its products include a range of nutraceutical products which are designed to improve health and wellness. Its products are G’Nest Deluxe and G’Nest Premium, and C’Neuros. Its services include RNA Mining/Mapping & Analytics Platform, Al-Enabled Platform, Cancer screening and diagnostics, Neurological and immunological precision medicine via proprietary genetic and epigenetic screening and diagnostic platforms, and Liquid biopsy based diagnostics for cancers using NGS technology.

Directors

    Last Annual
    June 30th, 2024
    Last Interim
    January 1st, 1970
    Incorporated
    December 22nd, 2023
    Public Since
    July 16th, 2024
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    au flag iconNational Stock Exchange of Australia
    Shares in Issue
    163,003,500
    Blurred out image of a map
    Address
    505 Little Collins Street, Level 6, MELBOURNE, 3000
    Web
    Phone
    Auditors
    HLB Mann Judd

    GD8 Share Price Performance

    Upcoming Events for GD8

    Similar to GD8

    Picture of VGI Health Technology logo

    VGI Health Technology

    au flag iconNational Stock Exchange of Australia

    Picture of IQX logo

    IQX

    au flag iconNational Stock Exchange of Australia

    FAQ